References
- Abad-Fernandez, M., Vallejo, A., Hernandez-Novoa, B., Diaz, L., Gutierrez, C., Madrid, N., Angeles Munoz, M., Moreno, S. (2013). Correlation between different methods to measure microbial translocation and its association with immune activation in long-term supressed HIV-1 infected individuals. J. Acquir. Immune Defic. Syndr., 64, 149–153.
- Albillos, A., de la Hera, A., Gonzalez, M., Moya, J.-L., Calleja, J.-L., Monserrat, J., Riuz-del-Arbol, L., Alvarez-Mon, M. (2003). Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology, 37 (1), 208–217.
- Balagopal, A., Phil, F. H., Astemborski, J., Block, T. M., Mehta, A., Long, R., Kirk, G. D., Mehta, S. H., Cox, A. L., Thomas, D. L., Ray, S. C. (2008). Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology, 135 (1), 226–233.
- Balagopal, A., Gama, L., Franco, V., Russell, J. N., Quinn, J., Higgins, Y., Smeaton, L. M., Clements, J. E., Thomas, D. L., Gupta, A. (2012). Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma. PLoS ONE, 7 (8), 1–8.
- Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med., 12, 1365–1371.
- Caradonna, L., Mastronardi, M. L., Magrone, T., Cozzolongo, R., Cuppone, R., Manghisi, O. G., Caccavo, D., Pellegrino, N. M., Amoroso, A., Jirillo, E., Amati, L. (2002). Biological and clinical significance of entotoxemia in the course of hepatitis C virus infection. Curr. Pharmaceut. Des., 8, 995–1005.
- Chan, C. C., Hwang, S. J., Lee, F. Y., Wang, S. S., Chang, F. Y., Li, C. P., Chu, C. J., Lu, R. H., Lee, S. D. (1997). Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand. J. Gastroenterol., 32 (9), 942–945.
- Crane, M., Iser, D., Lewin, S. R. (2012). Human immunodeficiency virus infection and the liver. World J. Hepatol., 4 (3), 91–98.
- Dinh, D. M., Volpe, G. E., Duffalo, C., Bhalchandra, S., Tai, A. K., Kane, A. V., Wanke, C. A., Ward, H. D. (2015). Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis., 211, 19–27.
- Epeldegui, M., Magpantay, L., Guo, Y., Halec, G., Cumberland, W. G., Yen, P. K., Macatangay, B., Margolick, J. B., Fositch, A. F., Wolinsky, S., Martinez-Maza, O., Hussain, S. K. (2018). A prospective study of serum microbial translocation biomarkers and risk of AIDS- related non- Hodgkin lymphoma. AIDS, 32 (7), 945–954.
- Epple, H.-J., Schneider, T., Troeger, H., Kunkel, D., Allers, K., Moos, V., Amasheh, M., Loddenkemper, C., Fromm, M., Zeitz, M., Schulzke, J.-D. (2009). Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV- infected patients. Gut, 58, 220–227.
- French, A., Evans, C. T., Agniel, D. M., Cohen, M. H., Peters, M., Landay, A. L., Desai, S. N. (2013). Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J. Infect. Dis., 208, 679–689.
- Hansjee, N., Kaufmann, G. R., Strub, C., Weber, R., Battegay, M., Erb, P. (2004). Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes. J. Acquir. Immune Defic. Syndr., 36, 671–677.
- Hatano, H. (2013). Immune activation and HIV persistence: Considerations for novel therapeutic interventions. AIDS, 8 (3), 211–216.
- Jiang, W., Lederman, M. M., Hunt, P., Sieg, S. F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A. I., Deeks, S. G., Douek, D. C., Brenchley, J. M. (2009). Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis., 199 (8), 1177–1185.
- Jirillo, E., Amati, L., Caradonna, L., Greco, B., Cozzolongo, R., Cuppone, R., Piazzolla, G., Caccavo, D., Antonaci, S., Manghisi, O. G. (1998). Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-α. Immunopharmacol. Immunotoxicol., 20 (1), 1–14.
- Kronenberger, B., von Wagner, M., Herrmann, E., Mihm, U., Piiper, A., Sarrazin, C., Zeuzem, S. (2005). Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J. Viral Hepat.,12, 307–314.
- Lopez-Cortes, L. F., Trujillo-Rodriguez, M., Baez-Palomo, A., Benmarzouk-Hidalgo, O. J., Dominguez-Molina, B., Milanes-Guisado, Y., Espinosa, N., Viciana, P., Gutierrez-Valencia, A. (2018). Eradication of hepatitis C virus (HCV) reduces immune activation, microbial trans-location, and the HIV DNA level in HIV/HCV-coinfected patients. J. Infect. Dis., 218 (4), 624–632.
- Macias, J., Japon, M. A., Saez, C., Palacios, R. B., Mira, J. A., Garcia-Garcia, J. A., Merchante, N., Vergara, S., Lozano, F., Gomez-Mateos, J., Pineda, J. A. (2005). Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus infection. J. Infect. Dis., 192, 1566–1576.
- Marchetti, G., Bellistri, G. M., Borghi, E., Tincati, C., Ferramosca, S., La Francesca, M., Morace, G., Gori, A., d`Arminio Monforte, A. (2008). Microbial translocation is associated with sustained failure in CD+ T-cell reconstitution in HIV-infected patients on long-term highly active anti-retroviral therapy. AIDS, 22, 2035–2044.
- Marchetti, G., Cozzi-Lepri, A., Merlini, E., Bellistri, G. M., Castagna, A., Galli, M., Verrucchi, G., Antinori, A., Costantini, A., Giacometti, A., di Caro, A., D’arminio Monforte, A. (2011). Microbial translocation predicts disease progression of HIV- infected antiretroviral- naïve patients with high CD4+ cell count. AIDS, 25, 1385–1394.
- Marchetti, G., Tincati, C., Silvestri, G. (2013). Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev., 26, 2–18.
- Marquez, M., Romero-Cores, P., Montes-Oca, M., Martin-Aspas, A., Soto-Cardenas, M.-J., Guerrero, F., Fernandez-Gutierrez, C., Giron-Gonzalez, J.-A. (2015). Immune activation response in chronic HIV-infected patients: Influence of hepatitis C virus coinfection. PLoS ONE, 10 (3), 1–15.
- Marks, M. A., Rabkin, C. S., Engels, E. A., Busch, E., Kopp, W., Rager, H., Goedert, J. J., Chaturvedi, A. K. (2012). Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS, 27, 469–474.
- Mhawej, M.-J., Brunet-Francois, C., Fonteneau, R., Ernst, D., Ferre, V., Stan, G.-B., Raffi, F., Moog, C. H. (2009). Apoptosis characterizes immunological failure of HIV infected patients. Control Eng. Practice, 17, 798–804.
- Nien, H.-C., Hsu, S.-J., Su, T.-H., Yang, P.-J., Sheu, J.-C., Wang, J.-T., Chow, L.-P., Chen, C.-L., Kao, J.-H., Yang, W.-S. (2017). High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments. PLoS ONE, 12 (1), 1–11.
- Novati, S., Sacchi, P., Cima, S., Zuccaro, V., Columpsi, P., Pagani, L., Filice, G., Bruno, R. (2015). General issues on microbial translocation in HIV-infected patients. Eur. Rev. Med. Pharmacol. Sci,, 19, 866–878.
- de Oliveira Pinto, L. M., Lecoeur, H., Ledru, E., Rapp, C., Patey, O., Gougeon, M.-L. (2002). Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro. AIDS, 16, 329–339.
- Parfieniuk-Kowerda, A., Lapinski T. W., Rogalska-Plonska, M., Swiderska, M., Panasiuk, A., Jaroszewicz, J., Flisika, R. (2013). Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C. Liver Int., 34, 544–550.
- Roger, P.-M., Breittmayer, J.-P., Durant, J., Sanderson, F., Ceppi, C., Brignone, C., Cua, E., Clevenbergh, P., Fuzibet, J.-G., Pesce, A., Bernard, A., Dellamonica, P. (2002). Early CD4+ T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation. J. Infect. Dis.,185, 463–470.
- Rohrbach, J., Stickel, F., Schmid, P., Thormann, W., Kovari, H., Scherrer, A., Gunthard, H. F., Vuichard, D., Cavassini, M., Ambrosioni, J., Bernasconi, E., Furrer, H., Rauch, A. (2013). Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals. Antiviral Ther., 19, 149–159.
- Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., Douek, D. C. (2011). Plasma levels of soluble CD14 independently predict mortality in HIV patients. J. Infect. Dis.,203, 780–790.
- Sandler, N. G., Douek, D. C. (2012). Microbial translocation in HIV infection: Causes, consequences and treatment opportunities. Nature Rev. Microbiol., 10, 655–666.
- Seidel, N., Volkmann, X., Langer, F., Flemming, P., Manns, M. P., Schulze-Osthoff, K., Bantel, H. (2005). The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology, 42, 113–120.
- Vassallo, M., Mercie, P., Cottalorda, J., Ticchioni, M., Dellamonica, P. (2012). The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: A systematic literature review. Virology J., 9 (174), 1–8.